Nothing in life is inevitable, aside from death and (for most people) taxes. Yet, as we explored in our previous article, there is in our view a range of factors that suggest PNG may well find itself ...

Minister Masiu sought an expert perspective on the use of AI in PNG, posing the question, “Is AI good for Papua New Guinea?” Dr. Nitheesh Murugan Kaliyamurthy, a Senior Lecturer and Program Manager at ...

Investigators assessed silmitasertib monotherapy in patients who had failed first-line hedgehog pathway inhibitors, with 27.3% also failing second-line PD-1 inhibitors such as cemiplimab (Libtayo) or ...

A new study in England shows a strong link between higher rates of chest x-ray referrals in general practice patients with symptoms, such as persistent cough, and earlier lung cancer diagnoses, along ...

Therefore, Senhwa will actively pursue licensing possibilities while carefully evaluating CX-4945's potential as a monotherapy or in combination with the second-line immunotherapy Libtayo. The company ...

Papua New Guinea Prime Minister James Marape has dismissed growing calls for his resignation, stating that any leadership change must follow parliamentary procedures. Upon his arrival at the APEC ...

and efficacy of solnerstotug as both a monotherapy and in combination with Regeneron’s PD-1 inhibitor Libtayo ® (cemiplimab) in patients with advanced solid tumors. Recent updates include ...

One patient with Merkel cell carcinoma (MCC) achieved a durable complete response with 15 milligrams per kilogram (mg/kg) solnerstotug and Libtayo (cemiplimab) and remains on treatment at 42 or more ...

Sensei is conducting a multi-center Phase 1/2 clinical trial to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of solnerstotug as both a monotherapy and in ...

Since independence in 1975, no government has ever shut down any form of media in PNG. Now on the eve of the anniversary of 50 years of independence, the government has taken this unprecedented action ...